Japan to unfurl more device "centres of excellence" plans
This article was originally published in Clinica
Executive Summary
A new round of discussions between US companies and the Japanese medical device authorities on the establishment of medical device "centres of excellence" is set for June. Delegates from AdvaMed, the US Advanced Medical Technology Association, will meet senior staff from the Ministry of Health and Welfare (MOHW) in Tokyo to talk about how local medical centres can qualify as such centres of excellence, and what the rewards for them will be. AdvaMed president Pam Bailey voiced hopes in January for such centres as a way of cutting costs for suppliers (see Clinica No 994, p 13).
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.